MML Investors Services’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
3,600
+427
+13% +$32.1K ﹤0.01% 2858
2026
Q1
$238K Sell
3,173
-91
-3% -$7.18K ﹤0.01% 2717
2025
Q4
$258K Buy
+3,264
New +$246K ﹤0.01% 2730
2024
Q1
Sell
-4,324
Closed -$219K 2524
2023
Q4
$219K Buy
+4,324
New +$207K ﹤0.01% 2262
2023
Q3
Sell
-5,956
Closed -$244K 2334
2023
Q2
$244K Buy
+5,956
New +$229K ﹤0.01% 2050
2022
Q3
Sell
-29,479
Closed -$1.09M 2113
2022
Q2
$1.09M Buy
29,479
+1,357
+5% +$51.2K 0.01% 1008
2022
Q1
$1.04M Buy
28,122
+2,905
+12% +$95.1K 0.01% 1066
2021
Q4
$767K Buy
25,217
+603
+2% +$19K 0.01% 1185
2021
Q3
$826K Buy
24,614
+1,828
+8% +$68.9K 0.01% 1107
2021
Q2
$909K Buy
22,786
+2,890
+15% +$113K 0.01% 1040
2021
Q1
$895K Buy
+19,896
New +$1.11M 0.01% 968
2020
Q1
Sell
-3,344
Closed -$202K 1474
2019
Q4
$202K Sell
3,344
-86
-3% -$5.12K ﹤0.01% 1431
2019
Q3
$205K Sell
3,430
-704
-17% -$45.9K ﹤0.01% 1387
2019
Q2
$266K Buy
4,134
+1,036
+33% +$73.2K ﹤0.01% 1353
2019
Q1
$251K Buy
+3,098
New +$200K ﹤0.01% 1358
2018
Q4
Sell
-4,669
Closed -$241K 1548
2018
Q3
$241K Buy
+4,669
New +$219K ﹤0.01% 1395

Other funds holding IONS

MML Investors Services's IONS Position: Q2 2026 in Review

MML Investors Services increased its Ionis Pharmaceuticals (IONS) stake by 13% in Q2 2026, buying an estimated $32.1K and bringing the position to 3,600 shares worth $285K. The position accounts for ﹤0.01% of the portfolio, ranked #2858.

MML Investors Services first reported a position in IONS in Q3 2018 and has held it in 16 quarters since. The position peaked at $1.09M in Q2 2022. 218 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • MML Investors Services held 3,600 shares of Ionis Pharmaceuticals worth $285K as of Q2 2026.
  • MML Investors Services bought 427 Ionis Pharmaceuticals shares in Q2 2026, an estimated $32.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2858 holding.
  • MML Investors Services first reported a position in Ionis Pharmaceuticals in Q3 2018 and has held it in 16 quarters since.
  • MML Investors Services's Ionis Pharmaceuticals position peaked at $1.09M in Q2 2022.
  • 218 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.